title: SCHEMA computational design of virus capsid chimeras: calibrating how genome packaging, protection, and transduction correlate with calculated structural disruption.
abstract: Adeno-associated virus (AAV) recombination can result in chimeric capsid protein subunits whose ability to assemble into an oligomeric capsid, package a genome, and transduce cells depends on the inheritance of sequence from different AAV parents. To develop quantitative design principles for guiding site-directed recombination of AAV capsids, we have examined how capsid structural perturbations predicted by the SCHEMA algorithm correlate with experimental measurements of disruption in seventeen chimeric capsid proteins. In our small chimera population, created by recombining AAV serotypes 2 and 4, we found that protection of viral genomes and cellular transduction were inversely related to calculated disruption of the capsid structure. Interestingly, however, we did not observe a correlation between genome packaging and calculated structural disruption; a majority of the chimeric capsid proteins formed at least partially assembled capsids and more than half packaged genomes, including those with the highest SCHEMA disruption. These results suggest that the sequence space accessed by recombination of divergent AAV serotypes is rich in capsid chimeras that assemble into 60-mer capsids and package viral genomes. Overall, the SCHEMA algorithm may be useful for delineating quantitative design principles to guide the creation of libraries enriched in genome-protecting virus nanoparticles that can effectively transduce cells. Such improvements to the virus design process may help advance not only gene therapy applications but also other bionanotechnologies dependent upon the development of viruses with new sequences and functions.
authors.affiliation: Department of Bioengineering and ‡Department of Biochemistry and Cell Biology, Rice University , Houston, Texas 77005, United States.
authors.forename: Michelle L
authors.initials: ML
authors.lastname: Ho
authors.forename: Benjamin A
authors.initials: BA
authors.lastname: Adler
authors.forename: Michael L
authors.initials: ML
authors.lastname: Torre
authors.forename: Jonathan J
authors.initials: JJ
authors.lastname: Silberg
authors.forename: Junghae
authors.initials: J
authors.lastname: Suh
mesh_terms: D000465:Algorithms; D002213:Capsid / Q000737:chemistry*; D002678:Chimera / Q000235:genetics* / Q000378:metabolism; D019295:Computational Biology; D000229:Dependovirus / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism; D016679:Genome, Viral; D006493:Heparin; D015202:Protein Engineering / Q000379:methods*; D011995:Recombination, Genetic / Q000235:genetics*
chemical_list: D006493:Heparin
references.citation: Chem Biol. 2004 Mar;11(3):309-18
references.pmid: 15123260
references.citation: Protein Eng Des Sel. 2004 Jul;17(7):589-94
references.pmid: 15331774
references.citation: Virology. 2009 Mar 15;385(2):434-43
references.pmid: 19144372
references.citation: Methods Enzymol. 2002;346:413-30
references.pmid: 11883083
references.citation: Genetics. 1974 Oct;78(2):737-56
references.pmid: 4448362
references.citation: Nanomedicine. 2010 Oct;6(5):634-41
references.pmid: 20433947
references.citation: J Gen Virol. 2011 Sep;92(Pt 9):2047-2059
references.pmid: 21632566
references.citation: PLoS Biol. 2006 May;4(5):e112
references.pmid: 16594730
references.citation: Nat Methods. 2009 May;6(5):343-5
references.pmid: 19363495
references.citation: J Virol. 2006 Dec;80(23):11556-70
references.pmid: 16971437
references.citation: Mol Ther. 2011 Apr;19(4):667-75
references.pmid: 21224831
references.citation: J Virol. 1998 Mar;72(3):2224-32
references.pmid: 9499080
references.citation: Chem Soc Rev. 2012 Sep 21;41(18):6178-94
references.pmid: 22880206
references.citation: Protein Eng Des Sel. 2011 Jan;24(1-2):53-63
references.pmid: 20923881
references.citation: Mol Ther. 2012 Feb;20(2):329-38
references.pmid: 22108859
references.citation: Viruses. 2011 Sep;3(9):1699-738
references.pmid: 21994803
references.citation: Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5380-5
references.pmid: 15809422
references.citation: Proc Natl Acad Sci U S A. 2003 May 13;100(10):6081-6
references.pmid: 12716974
references.citation: J Virol. 2009 Mar;83(6):2697-707
references.pmid: 19116260
references.citation: Protein Sci. 2013 Feb;22(2):231-8
references.pmid: 23225662
references.citation: J R Soc Interface. 2013 Jan 09;10(80):20120740
references.pmid: 23303217
references.citation: Clin Microbiol Rev. 2008 Oct;21(4):583-93
references.pmid: 18854481
references.citation: Mol Ther Nucleic Acids. 2012 Nov 13;1:e54
references.pmid: 23629029
references.citation: Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10220-5
references.pmid: 20479244
references.citation: Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10405-10
references.pmid: 12136130
references.citation: Adv Drug Deliv Rev. 2006 Dec 1;58(14):1505-22
references.pmid: 17118484
references.citation: J Virol. 2005 Apr;79(8):5047-58
references.pmid: 15795290
references.citation: Nat Struct Biol. 2002 Jul;9(7):553-8
references.pmid: 12042875
references.citation: Annu Rev Genet. 2001;35:275-302
references.pmid: 11700285
references.citation: Mol Ther. 2009 Nov;17(11):1888-96
references.pmid: 19532142
references.citation: J Virol. 2001 Aug;75(15):6884-93
references.pmid: 11435568
references.citation: Nat Biotechnol. 2000 Dec;18(12):1279-82
references.pmid: 11101807
references.citation: J Neurooncol. 2010 Feb;96(3):337-47
references.pmid: 19618115
references.citation: ACS Synth Biol. 2012 Jun 15;1(6):221-8
references.pmid: 22737599
references.citation: Curr Opin Chem Biol. 2006 Jun;10(3):246-52
references.pmid: 16678469
references.citation: Nat Rev Genet. 2008 Apr;9(4):267-76
references.pmid: 18319742
references.citation: Curr Gene Ther. 2010 Dec;10(6):423-36
references.pmid: 21054248
references.citation: Nat Biotechnol. 2006 Feb;24(2):198-204
references.pmid: 16429148
references.citation: Methods. 2002 Oct;28(2):158-67
references.pmid: 12413414
references.citation: J Virol. 2012 Dec;86(23):13038-48
references.pmid: 23015698
references.citation: Nat Biotechnol. 2007 Sep;25(9):1051-6
references.pmid: 17721510
references.citation: Protein Eng Des Sel. 2006 Dec;19(12):563-70
references.pmid: 17090554
references.citation: Gene Ther. 2012 Jun;19(6):694-700
references.pmid: 22402323
references.citation: Protein Sci. 2003 Aug;12(8):1686-93
references.pmid: 12876318
references.citation: Hum Gene Ther. 1994 Jul;5(7):793-801
references.pmid: 7981305
references.citation: J Virol. 2003 Jun;77(12):6995-7006
references.pmid: 12768018
references.citation: Curr Opin Struct Biol. 2007 Aug;17(4):454-9
references.pmid: 17884462
references.citation: J Virol. 2002 Jan;76(2):791-801
references.pmid: 11752169
references.citation: Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5610-5
references.pmid: 19307582
references.citation: Gene Ther. 1999 Jun;6(6):973-85
references.pmid: 10455399
references.citation: Chem Biol. 2007 Mar;14(3):269-78
references.pmid: 17379142
references.citation: Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3946-51
references.pmid: 19234115